{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:12:34Z","timestamp":1791414754468,"version":"4.3.3"},"reference-count":18,"publisher":"American Psychiatric Association Publishing","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[2004,5,1]]},"DOI":"10.1176\/appi.ajp.161.5.909","type":"journal-article","created":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T01:14:32Z","timestamp":1083374072000},"page":"909-911","source":"Crossref","is-referenced-by-count":41,"title":["Toward a Rapidly Acting Antidepressant: The Normetanephrine and Extraneuronal Monoamine Transporter (Uptake 2) Hypothesis"],"prefix":"10.1176","volume":"161","author":[{"given":"Joseph J.","family":"Schildkraut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Mooney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","reference":[{"key":"R1615BABCFCBC","doi-asserted-by":"crossref","unstructured":"Schildkraut JJ, Green R, Gordon EK, Durell J: Normetanephrine excretion and affective state in depressed patients treated with imipramine. Am J Psychiatry 1966; 123:690\u2013700","DOI":"10.1176\/ajp.123.6.690"},{"key":"R1615BABGIBEG","doi-asserted-by":"crossref","unstructured":"Schildkraut JJ, Dodge GA, Logue MA: Effects of tricyclic antidepressants on the uptake and metabolism of intracisternally administered norepinephrine-H3 in rat brain. J Psychiatr Res 1969; 7:29\u201334","DOI":"10.1016\/0022-3956(69)90009-0"},{"key":"R1615BABBCBCA","doi-asserted-by":"crossref","unstructured":"Schildkraut JJ, Winokur A, Applegate CW: Norepinephrine turnover and metabolism in rat brain after long-term administration of imipramine. Science 1970; 168:867\u2013869","DOI":"10.1126\/science.168.3933.867"},{"key":"R1615BABDHJAD","doi-asserted-by":"crossref","unstructured":"Schildkraut JJ, Winokur A, Drask\u00f3czy PR, Hensle JH: Changes in norepinephrine turnover in rat brain during chronic administration of imipramine and protriptyline: a possible explanation for the delay in onset of clinical antidepressant effects. Am J Psychiatry 1971; 127:1032\u20131039","DOI":"10.1176\/ajp.127.8.1032"},{"key":"R1615BABHCBCD","doi-asserted-by":"crossref","unstructured":"Burgen ASV, Iversen LL: The inhibition of noradrenaline uptake by sympathomimetic amines in the rat isolated heart. Br J Pharmacol 1965; 25:34\u201349","DOI":"10.1111\/j.1476-5381.1965.tb01754.x"},{"key":"R1615BABHHDJA","doi-asserted-by":"crossref","unstructured":"Schanberg SM, Schildkraut JJ, Breese GR, Kopin IJ: Metabolism of normetanephrine-H3 in rat brain\u2014identification of conjugated 3-methoxy-4-hydrophenylglycol as the major metabolite. Biochem Pharmacol 1968; 17:247\u2013254","DOI":"10.1016\/0006-2952(68)90330-4"},{"key":"R1615BABEDHBB","unstructured":"Glowinski J, Axelrod J: Effects of drugs on the disposition of H3\u2013norepinephrine in the rat brain. Pharmacol Rev 1966; 18:775\u2013785"},{"key":"R1615BABDCBHG","doi-asserted-by":"crossref","unstructured":"Nyb\u00e4ck HV, Walters JR, Aghajanian GK, Roth RH: Tricyclic antidepressants: effects on the firing rate of brain noradrenergic neurons. Eur J Pharmacol 1975; 32:302\u2013312","DOI":"10.1016\/0014-2999(75)90297-6"},{"key":"atypb1","doi-asserted-by":"crossref","unstructured":"Mateo Y, Pineda J, Meana JJ: Somatodendritic \u03b12 adrenoceptors in the locus coeruleus are involved in the in vivo modulation of cortical noradrenaline release by the antidepressant desipramine. J Neurochem 1998; 71:790\u2013798","DOI":"10.1046\/j.1471-4159.1998.71020790.x"},{"key":"R1615BABJFEFF","doi-asserted-by":"crossref","unstructured":"Linn\u00e9r L, Arborelius L, Nomikos GG, Bertilsson L, Svensson TH: Locus coeruleus neuronal activities and noradrenaline availability in the frontal cortex of rats chronically treated with imipramine: effect of \u03b12\u2013adrenoceptor blockade. Biol Psychiatry 1999; 46:766\u2013774","DOI":"10.1016\/S0006-3223(99)00126-2"},{"key":"R1615BABBFHFC","doi-asserted-by":"crossref","unstructured":"Lenz T, Werle E, Strobel G, Weicker H: O\u2013Methylated and sulfoconjugated catecholamines: differential activities at human platelet \u03b12\u2013adrenoceptors. Can J Physiol Pharmacol 1991; 69:929\u2013937","DOI":"10.1139\/y91-141"},{"key":"R1615BABFEFBH","doi-asserted-by":"crossref","unstructured":"Coyle JT, Schwarcz R: Mind glue: implications of glial cell biology for psychiatry. Arch Gen Psychiatry 2000; 57:90\u201393","DOI":"10.1001\/archpsyc.57.1.90"},{"key":"R1615BABGJAHH","doi-asserted-by":"crossref","unstructured":"Haydon PG: Glia: listening and talking to the synapse. Nat Rev Neurosci 2001; 2:185\u2013193","DOI":"10.1038\/35058528"},{"key":"R1615BABGEAAI","doi-asserted-by":"crossref","unstructured":"Hendley ED, Taylor KM, Snyder SH: 3H-Normetanephrine uptake in rat brain slices: relationship to extraneuronal accumulation of norepinephrine. Eur J Pharmacol 1970; 12:167\u2013179","DOI":"10.1016\/0014-2999(70)90062-2"},{"key":"atypb2","doi-asserted-by":"crossref","unstructured":"Henn FA, Hamberger A: Glial cell function: uptake of transmitter substances. Proc Natl Acad Sci USA 1971; 68:2686\u20132690","DOI":"10.1073\/pnas.68.11.2686"},{"key":"atypb3","doi-asserted-by":"crossref","unstructured":"Streich S, Br\u00fcss M, B\u00f6nisch H: Expression of the extraneuronal monoamine transporter (uptake2) in human glioma cells. Naunyn Schmiedebergs Arch Pharmacol 1996; 353:328\u2013333","DOI":"10.1007\/BF00168636"},{"key":"R1615BABIAGBJ","doi-asserted-by":"crossref","unstructured":"Gr\u00fcndemann D, Schechinger B, Rappold GA, Sch\u00f6mig E: Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter. Nat Neurosci 1998; 1:349\u2013351","DOI":"10.1038\/1557"},{"key":"R1615BABBDIAC","unstructured":"M\u00e4nnist\u00f6 PT, Kaakkola S: Catechol-O\u2013methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev 1999; 51:593\u2013628"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.161.5.909","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T09:55:51Z","timestamp":1722419751000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.161.5.909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5,1]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,5,1]]}},"alternative-id":["10.1176\/appi.ajp.161.5.909"],"URL":"https:\/\/doi.org\/10.1176\/appi.ajp.161.5.909","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"value":"0002-953X","type":"print"},{"value":"1535-7228","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5,1]]}}}